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Abstract
Background: Global prioritization of single-disease eradication programs over improvements to basic diagnostic
capacity in the Global South have left the world unprepared for epidemics of chikungunya, Ebola, Zika, and
whatever lies on the horizon. The medical establishment is slowly realizing that in many parts of sub-Saharan
Africa (SSA), particularly urban areas, up to a third of patients suffering from acute fever do not receive a
correct diagnosis of their infection.
Main body: Malaria is the most common diagnosis for febrile patients in low-resource health care settings,
and malaria misdiagnosis has soared due to the institutionalization of malaria as the primary febrile illness of
SSA by international development organizations and national malaria control programs. This has inadvertently
created a “malaria-industrial complex” and historically obstructed our complete understanding of the continent’s
complex communicable disease epidemiology, which is currently dominated by a mélange of undiagnosed febrile
illnesses. We synthesize interdisciplinary literature from Ghana to highlight the complexity of communicable disease
care in SSA from biomedical, social, and environmental perspectives, and suggest a way forward.
Conclusion: A socio-environmental approach to acute febrile illness etiology, diagnostics, and management would
lead to substantial health gains in Africa, including more efficient malaria control. Such an approach would also
improve global preparedness for future epidemics of emerging pathogens such as chikungunya, Ebola, and Zika, all of
which originated in SSA with limited baseline understanding of their epidemiology despite clinical recognition of these
viruses for many decades. Impending ACT resistance, new vaccine delays, and climate change all beckon our attention
to proper diagnosis of fevers in order to maximize limited health care resources.
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Background
Global funding for malaria alone reached US$2.7 billion
in 2013, a threefold increase from 2005 [1], amid calls by
leading malaria research institutions to further scale up
funding of malaria control programs [2, 3]. The World
Health Organization (WHO) estimated that investments
would have to grow to US$6.4 billion by 2020, and
US$8.7 billion by 2030 to achieve its global target for a
90% reduction in malaria transmission [4]. Amid vast
diagnostic resource constraints in sub-Saharan Africa
(SSA), malaria has traditionally been the de facto pre-
sumptive diagnosis for patients experiencing acute
febrile illness (AFI), a category that encompasses half of
clinical visits in many SSA nations. Successful malaria
control efforts have lowered malaria transmission in SSA
[5] to the point where bacterial and viral pathogens now
drive AFI in the region [6–9]. But the global burden of
AFI remains unknown due to limited focus on fever, and
estimating this burden is ridden with challenges [10].
While malaria’s landscape ecology has traditionally
been rural, the typical SSA capital has experienced per-
sistent annual urban growth rates of 5–6% driven largely
by rural-to-urban migration, with some cities growing in
excess of 10% annually, implying population doubling
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every decade [11]. The urban ecology that is home to an
increasing proportion of SSA’s population—over half in
many nations—supports much lower levels of malaria
transmission [12]. Misdiagnosis issues and urbanization
trends are conspicuously ignored in high-profile malaria
analyses which: purport a larger burden than previously
estimated [13]; attribute the averting of 663 million clin-
ical cases solely to insecticide-treated bed nets (ITNs),
indoor residual spraying (IRS), and artemisinin-based
combination therapy (ACT) [14]; and model optimal
deployment of these intervention strategies [15]. In
resource-constrained SSA, a region on pace for the
world’s highest rates of population growth over the next
half-century [16], most febrile illnesses are still presump-
tively treated as malaria despite growing evidence that,
especially in urban contexts, malaria is probably not a
major problem. Yet the global health and development
communities remain disproportionately focused on mal-
aria control, which often results in an outpouring of
funds into preventative consumables and management
with relatively little measurement and evaluation. Des-
pite having the best of intentions, this creates a cycle of
policy and monetary relationships between international
donors, local government, and national malaria control
programs that we call the “malaria-industrial complex.”
A socio-environmental approach to understanding the
etiology of febrile illness integrates biomedical consider-
ations with the scientific, economic, and socio-political
realities wrought by society’s increasing detachment
from the physical environment [17]. This is similar to
the One Health approach, which recognizes the inter-
connectedness of humans, animals, and the environ-
ment, but with a greater emphasis on the social context
within which these actors produce effects on health
within social-ecological systems [18]. This paper argues
that the global health community needs to convene
interdisciplinary groups of experts to embrace an inte-
grated approach for AFI, and offers Ghana as a case
study to highlight the obstacles to developing a more
comprehensive focus on communicable disease diagnos-
tics across SSA. Malaria is certainly still an important
problem in many parts of the world, but malaria control
strategies could be far more targeted and efficient if we
had a better handle on febrile illness etiology. In the
meantime, West Africa—given its growth rate and de-
pletion in capacity following the Ebola epidemic—will
continue to be a frontline for a host of neglected tropical




Malaria misdiagnosis receives little attention but remains
a common problem throughout SSA [19–28], with a
greater burden on poor communities [29, 30]. In high-
transmission, low-resource settings, health care facilities
have historically depended on clinical algorithms for
malaria case management [21]. A clinical algorithm will
indicate a diagnosis of malaria given a defined set of pre-
dictor symptoms and signs such as intermittent fever,
chills, and an enlarged liver and spleen [31]. But because
the symptoms of non-severe malaria resemble those of
most AFI, clinical algorithms for malaria typically result
in fewer true-negatives and a higher rate of false-
positives [25, 31], thus impeding differential diagnosis
[32, 33]. Because the presence of fever is often presump-
tively treated as malaria, even when malaria may not be
circulating [28], the true burden of diseases such as ty-
phoid, influenza, and dengue fever are likely understated
in SSA [34]. This was a contributing factor in WHO’s
2010 revision to malaria care guidelines to recommend
confirmation of all suspected malaria cases by parasito-
logical test [35]. Yet even where evidence-based guide-
lines exist for malaria diagnosis, health care provider
adherence to guidelines can be problematic [36].
A study from Tanzania highlights the diverse etiology
of AFI. Of 870 hospital admissions, 528 (60.7%) patients
were clinically diagnosed with malaria, but only 14
(1.6%) actually had malaria parasites upon subsequent
blood analysis. Ten different kinds of infections, includ-
ing bloodstream infections, bacterial and fungal infec-
tions, and arboviruses, were all presumptively diagnosed
as malaria based on clinical symptoms [19]. But this
study was conducted in Moshi, a city of roughly 144,000,
which may not be representative of the local disease
ecology of large, tropical SSA urban agglomerations
like Luanda, Dar es Salaam, Abidjan, Nairobi, or
Accra, much less emerging megacities like Lagos or
Kinshasa-Brazzaville. We are just beginning to realize
how little we know about communicable disease epi-
demiology in SSA.
Results of studies assessing local rates of malaria mis-
diagnosis are trickling out of SSA. In Nigeria, 83% of
children under 5 years old received ACT even after test-
ing negative for malaria via microscopy [37]. Clinical
and home-based presumptive treatment of malaria re-
mains common and has probably masked actual malaria
transmission reduction in some countries [38], particu-
larly in urban areas. Malaria over-diagnosis in SSA also
suffers from high clinical workloads, variable health
worker training and lab techniques, and low laboratory
capacity [39]. Because many fevers are still treated at
home (using both modern and traditional medicines),
clinical data greatly underestimates the enormity of AFI
in SSA [30, 40]. In hyper- and holoendemic regions, natur-
ally acquired immunity provides protection against malaria,
as infected adults routinely maintain a level of parasite
prevalence that would otherwise kill a malaria-naïve
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visitor, but without experiencing overt disease them-
selves [41]. This further complicates the proper diag-
nosis of AFI, as febrile patients presumed to have
malaria may test positive on a highly-sensitive malaria
rapid diagnostic test (RDT) due to a low parasite load
that their immune system keeps in check, yet actually
be suffering from another infection. We need to re-
think the concept of misdiagnosis by systematically
establishing the baseline epidemiology for all major
sources of fever while also confronting the many
non-biomedical perceptions of fever among local
communities [42]. The burden of communicable dis-
eases in SSA remains heterogeneous and enigmatic
[6], and recent findings raise important questions
about the interaction between demography, malaria
control, and other neglected tropical diseases. We can
look to Ghana as an important case study.
Ghana: clinical consequences
Ghana’s 2014 population of 27 million was 51% urban
[43], though according to WHO, the entire nation is still
considered a high transmission zone for Plasmodium
falciparum malaria, the most dangerous of the malaria
parasite species that infects humans [44]. The 2014
World Malaria Report notes over 20,000 malaria deaths
in Ghana between 2000 and 2013, with 2,506 in 2013
[1]. More than half of all clinic visits in Ghana are due
to febrile illness [45]. Ghana received about US$100 mil-
lion for malaria control from international and domestic
funders in 2013 alone, an amount that fluctuated be-
tween $72–110 million from 2010 to 2014 [44]. In 2013
over 75% was spent on insecticides, insecticide-treated
bed nets, and antimalarials, while only approximately
13% was spent on diagnostics—an amount less than the
amount reportedly spent on management costs—and
just 1–2% was spent on monitoring and evaluation [1].
In 2014, the amount spent on diagnostics fell to approxi-
mately half of 2013 levels [44]. Many health care facil-
ities still lack RDTs, and just 23% of Ghana’s reported
malaria cases were confirmed via microscopy or RDT in
2013; the balance were presumptively diagnosed [1].
Ghanaian clinical staff nationwide were found to be
diagnosing approximately nearly half of sick children
(and nearly 40% of all outpatients) with malaria, with
fewer than a third of diagnoses confirmed via micros-
copy [46]. From 2001 to 2006, 47% of outpatient facility
visits by children in Accra—and 37% of adult visits—re-
sulted in a clinical malaria diagnosis [47]. The same
study also highlighted how rainfall over the prior two
months was a significant predictor of malaria morbidity.
We have long understood the association between rain-
fall, mosquito breeding, and malaria [48], and this has
contributed toward the institutionalized view that sea-
sonal spikes in fevers during rainy seasons are primarily
attributable to malaria. While this is true, rainfall ampli-
fies many other mosquitoes of public health importance
such as Aedes and Culex, as well as water-borne and
water-washed pathogens when flood waters breach inad-
equate sanitation infrastructure [49]. Typhoid fever may
be prone to misdiagnosis as malaria during periods of
heavy rain, and child pneumonia has been shown to
present clinically with malaria-like symptoms in SSA
[33, 50]. A 2009–2010 Accra study of 605 feverish chil-
dren suspected of malaria yielded a parasite-positive rate
of just 11% after blood microscopy, yet 80% were diag-
nosed with malaria and prescribed anti-malarials [51].
All of the evidence suggests that malaria incidence data
do not accurately represent Ghana’s malaria burden [46],
and are consistent with observations of very low parasit-
emia levels (1.5%) in Accra made 25 years ago despite
similar frequency of fever as in rural areas [52].
Dengue exposure with probable local transmission was
recently demonstrated in Ghana [53]. The study tested
archived plasma samples from 218 children aged 2–14
years who tested positive for malaria at local health facil-
ities in three Ghanaian cities, and found previous dengue
exposure in 21.6% and recent exposure in 3.2% of the
children sampled. Notably, this study screened the
opposite population—lab-confirmed malaria patient-
s—whom we would not normally evaluate for other
sources of infection. Therefore there is a real possibility
of dengue infections (and potentially other arbovirus in-
fections) in malaria-negative febrile illness patients,
which highlights the complexity of febrile illness in
Ghana. These findings are most certainly just the tip of
the iceberg for communicable disease epidemiology in
Ghana, and across SSA. But clinical revelations must be
complemented by advances in environmental and com-
munity health.
Insect disease vectors thrive in Ghana’s urban area-
s—and likewise in most SSA nations—due to poor sani-
tation infrastructure, regular rainy seasons, widespread
household water storage due to limited drinking water
availability, and low public awareness of vector control
behaviors. Among the most important mosquito vectors
are Aedes aegypti, the primary vector for dengue, Zika,
chikungunya, and yellow fever, and Culex spp, vectors
for several diseases including West Nile virus, filariasis,
and Japanese encephalitis [54–57]. Entomological sur-
veys have documented Ae. aegypti in West Africa for
over one hundred years [58], and the entomological lit-
erature relating to arboviral diseases in Ghana is decades
old [59–63]. Dengue fever, for example, does not appear
in the Ghanaian medical literature until the 21st century
even though dengue was reported in seven West African
nations with a mortality rate of about 5% [64], and Ae.
aegypti has reappeared in mosquito surveys for over fifty
years [59, 62, 65–67]. The breeding density and biting
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behavior of Ae. aegypti were found to be sufficient for
facilitating an outbreak of dengue in four northern
Ghanaian communities over a decade ago, though flavi-
viruses had still not been isolated from mosquito catches
[65]. The last mosquito survey of Accra published in the
scientific literature, conducted in 2003, reaffirmed the
presence of Anopheles, Culex, and Aedes, but focused on
just six communities [66].
Culex mosquitoes are the most common mosquitoes
of public health importance documented in Accra due
to their ability to breed in highly polluted water found in
sewers and discharge basins [66, 67]. Culex will also
breed alongside Ae. aegypti in man-made containers and
pockets of rainwater that collect in refuse piles. Accra’s
historical potable water shortages and subsequent muni-
cipal water rationing induce widespread household water
storage [68], which in turn exacerbate the breeding of
Aedes and Culex mosquitoes by amplifying the number
and density of urban breeding sites. In contrast, Ghana’s
primary malaria vector, Anopheles gambiae, is a trad-
itionally rural pest which prefers clean, still or slow-
moving water near vegetation as is typically found in
irrigation canals [60]. An. gambiae may be adapting to
polluted water in SSA [67, 69–71], but the solid waste
problem has never been demonstrated to provide
enough Anopheles breeding habitat to support malaria
transmission relative to the heightened risk for viral
infections posed by Aedes or Culex mosquitoes.
Still, a recent study of health perceptions in Accra
affirmed the significance of malaria as a primary health
threat that cuts across communities of all socio-
economic levels [72]. The linking of malaria to inad-
equate sanitation was a persistent theme as residents of
both high- and low-income neighborhoods associated
uncollected refuse and clogged drains with mosquito
breeding—and thus malaria—with less concern for trad-
itional sanitation-driven diseases such as typhoid fever.
This linkage of malaria and garbage was the most popu-
lar health misperception reported across Accra, and
likely contributes toward the popular perception of a
heavy malaria morbidity burden in Ghana [72]. The gen-
eral lack of knowledge about malaria transmission
among Ghana’s populace is old news, and in some re-
gions, local words for fever and malaria have historically
been used interchangeably [73]. Fever has also not al-
ways had such an ubiquitous association with mosqui-
toes, particularly in rural Ghana [74]. Worse still,
previous studies in Ghana have observed that in the ab-
sence of an intervention, higher knowledge of malaria is
not necessarily associated with protective behaviors [75,
76]. In summary, the accumulated evidence from Ghana
beckons an approach to fever that integrates biomedical
advances with social, behavioral, and environmental
levers of patient management.
A socio-environmental approach
There are significant gaps in biomedical diagnostic capacity
and a staggering lack of baseline data describing the under-
lying etiology of AFI cases in SSA. Improving differential
diagnoses for AFI requires better physician training and
clinical algorithms that pinpoint hallmark features [77], and
are contextualized by rich local communicable disease
epidemiology. The expansion of clinical screening thus
suggests the reprioritization of limited health resources.
We need to return to public health basics: community-
level surveillance coupled with rigorous assessment of
knowledge, attitudes, and practices related to febrile ill-
nesses, an approach that has been used in Ghana in a
variety of malaria-related studies [75, 76, 78]. Many rich
geographic data sets have been used in previous works on
health, poverty, and place in Accra, including georefer-
enced census data, land cover data derived from satellite
imagery, water and other infrastructure availability, and
household health data, including self-reported malaria (i.e.
a proxy for febrile illness) [79]. Practitioners can leverage
prior research on characterization of urban neighborhoods
to produce high-resolution risk maps of environmental
risk factors such as vector species. Traditional epidemio-
logical methods can link environmental factors, demo-
graphic characteristics, health behaviors, and hallmark
symptoms with confirmed diagnoses. These are precisely
the tools used in outbreak investigations, though many
SSA nations still have underfunded surveillance systems
that hamper timely outbreak detection and response,
particularly in those West African nations whose clinical
and public health infrastructures were devastated by Ebola
in 2015 [80]. The Integrated Disease Surveillance and
Response (IDSR) framework, adopted by the WHO
African Regional Office for Africa in 1998, aims to
improve detection and response by public health man-
agers and decision-makers in African nations and
shows great promise for strengthening surveillance
systems. But IDSR has not been a panacea, as a recent
implementation in northern Ghana has been fraught
with “low priority for surveillance, ill-equipped labora-
tories, rare supervision and missing feedback” [81]. The
implementation of the International Health Regulations
[IHR(2005)], which became international law in 2007,
has also reported gaps in disease surveillance capacity
as well as leadership, communication, and collaborative
challenges [82], though it remains an important vehicle
for responding to global public health emergencies [83].
But we also need to improve our understanding of
how patients and clinicians perceive AFI, craft targeted
educational messages—which integrate our vector ecol-
ogy findings—for both the public and clinicians, inte-
grate new diagnostic heuristics into clinical practice, and
measure the heuristic’s effectiveness. Many social, eco-
nomic, and institutional factors are associated with the
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propensity for seeking care for AFI. Previous work in
Tanzania showed that AFI patients did not necessarily
pressure clinicians into issuing a malaria diagnosis, and
that malaria over-diagnosis may have been attributable
to a mismatch between patient expectations and clin-
ician perceptions [22]. Clinicians, on the other hand,
were subject to pressures from their initial malaria-
centric training, their peers, and perceived patient ex-
pectations, in addition to having shared rationales about
malaria being easier and more socially acceptable to
diagnose [21]. The problem of misdiagnosed AFI in SSA
is therefore partly knowledge- and behavior-driven. This
requires both patient- and clinician-centric approaches
to integrating health education with technology-driven
diagnostic changes.
Technology and training
Many RDTs for tropical infections are new, and some
have not yet been rigorously tested in SSA [84]. There
remain unknown issues of cross-reactivity among bacter-
ial and viral families, which has remained a problem
around the world among flaviviruses [85, 86]. Cross-
reactivity has been observed between dengue and both
chikungunya and leptospirosis, as well as in some
malaria-positive patients [87]. Molecular methods do
not have these limitations, but the cost and technical
and logistical expertise associated with such methods
currently limit rapid deployment and geographically-
scalable solutions to differential diagnosis. Commercial
serology kits, RDTs, and innovative point-of-care diag-
nostic products are more suitable, but require ongoing
characterization of cross-reactivity as our knowledge of
communicable disease epidemiology grows. Fortunately,
some new RDT products have demonstrated better sen-
sitivity and specificity than microscopy when compared
to DNA-based polymerase chain reaction [88]. Other
innovations, such as TaqMan array cards that can simul-
taneously detect dozens of pathogens at a time in less
than three hours, show promise as screening tools
during outbreak investigations [89]. New mobile and
handheld technology also has the potential to transform
diagnostic accuracy. Recent trials of tablet-based diag-
nostic algorithms have vastly improved AFI diagnosis
and pushed antibiotic prescription rates—which are
largely driven by anti-malarials—from 84 to 15.4% [90].
Mobile devices show promise for improving the manage-
ment of childhood fevers [91, 92], particularly with elec-
tronic versions of WHO’s Integrated Management of
Childhood Illness strategy [93].
Improved health care worker training will be cru-
cial, as prior research has shown that merely the
presence of new diagnostic technology such as RDTs
in the absence of training can lead to wasted costs,
and that the combination of RDTs and training leads
to more sustainable improvements in the quality of
diagnosis [94]. For example, although 41 of 44 na-
tions in the WHO African Region now require mal-
aria diagnostic testing across age groups and RDT
procurement has soared, diagnostic processes and
treatment still vary widely [95]. Diagnostic testing in
SSA continues to be limited by RDT stockouts, inef-
ficient patient flow in health care facilities, and lack
of provider adherence to test results. In many set-
tings, physicians are reluctant to prescribe the treat-
ment that is appropriate given diagnostic results,
and additional health education is thus essential for
clinicians [45].
In Ghana, active learning approaches that engage clini-
cians with the medical literature and local research
teams have previously been associated with improved
clinical practices in malaria care [96]. But efforts to im-
prove the training of Ghanaian health care workers with
regard to AFI are subject to a variety of socio-cultural
considerations [97]. For example, a recent trial in rural
Ghana demonstrated that the introduction of RDTs in
absence of microscopy can substantially reduce malaria
over-diagnosis and over-prescription of anti-malarials,
but that there is limited impact where microscopy
already exists [98]. But these modern nuances in care
are mediated by historical difficulties deploying trained
and motivated staff in all regions of Ghana [99, 100]. Pa-
tient perceptions may also influence diagnosis of febrile
illness [101]. An evidenced-based approach to febrile
illness thus requires a nimble health education com-
ponent that motivates and empowers health care
workers and patients alike to value differential diag-
nosis of AFI. Greater community member awareness
of malaria transmission has been associated with bet-
ter adherence to vector control interventions [102, 103],
and we can leverage these lessons toward proper manage-
ment of fever. A prototype for febrile-illness-related
health communication is currently being piloted as a
“Test and Treat” campaign in Nigeria by a group
called Support to National Malaria Programme
(SuNMaP).
Conclusion
A socio-environmental approach to acute febrile illness
etiology, diagnostics, and management provides several
opportunities for integrated research into: (1) scalability of
recent advances in diagnostic technology both in the lab
and field; (2) geo-demographic and socio-environmental
correlates of specific communicable diseases that contrib-
ute to SSA’s febrile illness burden; (3) the environmental
and human behavioral drivers of vector breeding, as well
as assessing integrated vector management techniques
that have been successfully deployed in other tropical
urban contexts; and (4) the testing of various community-
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level educational and behavioral interventions related to
febrile illness knowledge and care-seeking, particularly
given the matrix of caregivers (family, pharmacists, physi-
cians, traditional healers, etc.) available within relatively
close proximity in any large sub-Saharan African city.
Toward these ends, we summarize some proposed key
solutions ranging from clinical to institutional scales:
 Renew the focus on differential diagnosis in tropical
medicine and public health training;
 Initiate or improve community-level health
communication about febrile illness causes and care;
 Pilot the reallocation of malaria-related health care
resources in low-transmission urban settings to support
febrile illness diagnostics (which includes malaria);
 Encourage local and international funding agencies
to prioritize health worker training and laboratory
diagnostic capacity.
As the global health community braces itself for the
next Ebola- or Zika-like pandemic and sets new mile-
stones in accordance with the United Nations’ Sustain-
able Development Goals, we must not lose sight of the
basics: Africa’s communicable disease burden—and con-
sequently our world’s—will persist until we commit to
getting the diagnosis right the first time. As attention
turns to non-communicable diseases in the Global South
in recognition of these nations’ double burden of disease
[104, 105], it is increasingly clear that we still have much
to learn about infectious disease morbidity and mortality
in SSA. And that’s to say nothing of emerging ACT re-
sistance creeping across South Asia [106], modest results
in malaria vaccine trials [107, 108], and the impact of cli-
mate change on communicable disease epidemiology
[109], all of which present critical, near-term challenges
that underscore the urgency of proper AFI management
in SSA. Contemporary neglect of communicable disease
epidemiology in SSA is perhaps best captured in com-
ments from Wilber Downs during his Thirty-Sixth
Annual Theobald Smith Memorial Lecture at the New
York Society of Tropical Medicine in 1974, despite four
decades of medical advances:
Whose responsibility is it to engage in such a
program? Certainly the local governments have prime
responsibility, backed up by the World Health
Organization for necessary inter-regional studies. In-
terested foreign governments, mission groups, and
foundations, it is to be hoped, will provide backing, as
they have done in the past. But I cannot permit myself
to be optimistic. At this time what is being done by all
parties combined to improve the situation with re-
spect to the diagnosis of infectious diseases in Africa
is utterly inadequate [110].
Misdiagnosis of febrile illness persists as an understudied
health problem in SSA, while global focus on malaria eradi-
cation has bred a malaria-industrial complex that diverts
resources from more common sources of acute fever,
especially in urban areas. Rates of malaria misdiagnosis
are exacerbated by limited health care resources, clinician
and patient perceptions of fever, and limited community
knowledge of disease ecology. A socio-environmental
approach to febrile illness would help overcome many
social and clinical barriers to effective diagnosis and
patient management.
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